A Clinical Trial of Intracavernous Vasoactive Intestinal Peptide to Induce Penile Erection

摘要: AbstractA double-blind, placebo-controlled clinical trial of the intracavernous injection vasoactive intestinal peptide was conducted and studied in 24 men with erectile dysfunction diabetic, neurogenic psychogenic etiology. The patients were randomized into 6 groups 4 subjects each received either placebo, or 200 400 pmol. at 3 consecutive weekly visits. An increase penile length associated significantly treatment (F equals 5.10, p 0.01), dose-related, independent time sequence treatment. diameter 8.14, 0.001) 0.001), dose-related Penile rigidity 5.44, 0.008), nearly 3.11, 0.056) Despite some ...